Nasopharyngeal carcinoma is a common clinical disease, especially in the southern regions of China. It primarily affects the nasal area as a malignant tumor. The clinical treatment outcomes for nasopharyngeal carcinoma are relatively good, and it is also referred to as "fortunate cancer," which implies that it has a relatively high cure rate. The main clinical treatment involves radiation therapy combined with chemotherapy, often described as the "sandwich" treatment method. Any tumor can be cured if detected early, and the early detection rate of nasopharyngeal carcinoma is relatively high. Therefore, its cure rate is also relatively high compared to other major organ tumors such as liver and lung cancers, which exhibit relatively lower cure rates and outcomes.